Real-world Study of the Safety and Efficacy of Pembrolizumab in the Treatment 
of Advanced Non-small Cell Lung Cancer

Real-world Study of the Safety and Efficacy of Pembrolizumab in the Treatment 
of Advanced Non-small Cell Lung Cancer

Background and objective Pembrolizumab (PEM) has been shown to be effective in clinical trials for the treatment of advanced non-small cell lung cancer (NSCLC), but clinical trials were based on cohorts of patients selected on specific criteria, and whether the findings are consistent with real-worl...

Full description

Saved in:
Bibliographic Details
Main Authors: Ning WAN, Bing WANG, Ya GUO, Zijian HE, Chen YANG, Ning YANG, Liqing LU, Hongyi LIANG, Weibin XIAO, Dandan YANG, Zhuojia CHEN, Wenfeng FANG, Weiting LIANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2024-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
real-world data
pembrolizumab
lung neoplasms
safety
efficacy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2024.106.29
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2024.106.29

Similar Items